Mylan's Robert Coury - CEO Pay

Robert Coury, Mylan CEO

Robert Coury - Mylan

Total Compensation: $8.54M

2007 Revenue: $2.17B
2006 Revenue: $1.61B
Change: 34%

Details: Mylan CEO and Vice Chairman Robert Coury brought down $10.3 million during fiscal 2007, which ran only nine months because the drugmaker changed its fiscal year. Coury earned salary of about $1.12 million, stock awards of $1.15 million, and about $2.1 million in incentive compensation. Mylan was the only company that primarily produces generics drugs to grace our top 17.

Mylan News:
Mylan CEO intent on new global biz
Mylan CEO makes $10M in 9 months

Mylan's Robert Coury - CEO Pay
Read more on

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.